Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity of PPSV-23 After PCV-13 in Adult Asthmatic Patients
NCT03260790Phase 4Completed
- Sponsor
- Mayo Clinic
- Start
- Oct 2017
- Primary completion
- Dec 2020
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of Prevnar 13 in pneumococcal disease, sponsored by Mayo Clinic. Started Oct 2017; status: completed.
02
Drugs
Prevnar 13
03
Conditions
pneumococcal disease
Beyond the preview
Go deeper on NCT03260790.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03260790.